Vikram Verghese Sells 6,640 Shares of Heartflow (NASDAQ:HTFL) Stock

Key Points

• Heartflow CFO Vikram Verghese sold 6,640 shares at an average price of $50.03, generating $332,199.20. The transaction occurred under a pre-arranged Rule 10b5-1 plan and reduced his direct ownership by 3% to 214,503 shares.
• Heartflow shares recently fell 2.5% to $45.49, while the company reported quarterly revenue of $64.08 million, up 47.7% year over year, and an adjusted loss of $0.07 per share that beat analyst expectations.
• Analysts maintain a generally positive outlook, with a consensus rating of “Moderate Buy” and an average price target of $44.88, although the stock’s current price is above that target.

Heartflow, Inc. (NASDAQ:HTFL - Get Free Report) CFO Vikram Verghese sold 6,640 shares of Heartflow stock in a transaction that occurred on Tuesday, September 8th. The shares were sold at an average price of $50.03, for a total transaction of $332,199.20. Following the sale, the chief financial officer directly owned 214,503 shares in the company, valued at $10,731,585.09. This trade represents a 3.00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Vikram Verghese also recently made the following trade(s):

• On Thursday, September 3rd, Vikram Verghese sold 27,540 shares of Heartflow stock. The shares were sold at an average price of $49.69, for a total transaction of $1,368,462.60.
• On Wednesday, September 2nd, Vikram Verghese sold 5,876 shares of Heartflow stock. The shares were sold at an average price of $50.60, for a total transaction of $297,325.60.

Heartflow Stock Down 2.5%

Shares of NASDAQ HTFL traded down $1.18 during midday trading on Thursday, reaching $45.49. 2,256,650 shares of the company were exchanged, compared to its average volume of 1,550,843. The stock's 50-day moving average price is $34.73 and its 200-day moving average price is $30.50. The stock has a market cap of $3.96 billion and a P/E ratio of -24.86. Heartflow, Inc. has a one year low of $20.13 and a one year high of $51.78.

Heartflow (NASDAQ:HTFL - Get Free Report) last announced its quarterly earnings results on Thursday, August 13th. The company reported ($0.07) EPS for the quarter, beating analysts' consensus estimates of ($0.22) by $0.15. The company had revenue of $64.08 million during the quarter. Heartflow had a negative return on equity of 23.52% and a negative net margin of 55.82%.The company's revenue for the quarter was up 47.7% on a year-over-year basis. On average, equities research analysts anticipate that Heartflow, Inc. will post -0.75 EPS for the current year.

Analyst Upgrades and Downgrades

HTFL has been the subject of several recent research reports. Freedom Capital raised Heartflow to a "strong-buy" rating in a research note on Tuesday, June 30th. Robert W. Baird set a $45.00 price target on shares of Heartflow in a research report on Friday, August 14th. Benchmark reaffirmed a "buy" rating on shares of Heartflow in a research note on Friday, August 14th. Stifel Nicolaus lifted their price target on shares of Heartflow from $40.00 to $45.00 and gave the stock a "buy" rating in a report on Friday, August 14th. Finally, UBS Group started coverage on shares of Heartflow in a research note on Wednesday. They issued a "neutral" rating and a $55.00 price objective on the stock. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $44.88.

Hedge Funds Weigh In On Heartflow

A number of institutional investors and hedge funds have recently modified their holdings of the business. Vanguard Group Inc. bought a new stake in shares of Heartflow in the 3rd quarter valued at $48,871,000. Legal & General Group Plc acquired a new stake in Heartflow in the third quarter worth $59,000. Franklin Resources Inc. acquired a new stake in Heartflow in the third quarter worth $10,829,000. UBS Group AG bought a new stake in Heartflow in the third quarter valued at $5,130,000. Finally, Sei Investments Co. acquired a new position in shares of Heartflow during the third quarter valued at about $303,000.

Heartflow Company Profile

HeartFlow, Inc NASDAQ: HTFL is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company's core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow's analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow's cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.